Industry

Double Homeobox Protein 4 Drugs Market Research Report 2022: Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Double Homeobox Protein 4 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. Double Homeobox Protein 4 (Double Homeobox Protein 10 or DUX4) Drugs in Development report provides in depth analysis on Double Homeobox Protein 4 (Double Homeobox Protein … [Read more…]

2022 Military Medical Device Technologies Report – Easy-to-Use and Quick Wound Sealing Hemostatic Solutions for Trauma Injuries Presents Opportunities – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Growth Opportunities in Military Medical Device Technologies” report has been added to ResearchAndMarkets.com’s offering. Over the years, the healthcare industry has developed several unique technologies for emergency medical services and critical care. An important user of critical care healthcare products is the military or the defense forces. Advanced medical technologies have improved the … [Read more…]

T Cell Specific Surface Glycoprotein CD28 Drugs Pipeline Research Report 2022: Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “T Cell Specific Surface Glycoprotein CD28 Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. … [Read more…]

Osivax Secures EUR 10M Grant from Bpifrance to Support Clinical Development of OVX836, a Broad-Spectrum Influenza Vaccine

LYON, France–(BUSINESS WIRE)–Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses and diseases, today announced that it has secured EUR 10M from Bpifrance to support the further clinical development of OVX836, its lead broad-spectrum influenza vaccine candidate. The grant financing is part of the Healthcare Innovation 2030 plan by … [Read more…]

U.S. House Calls Market Size, Share & Trends Analysis Report 2022-2030: Emergence of On-demand Physician House Calls via Mobile-based Apps – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “U.S. House Calls Market Size, Share & Trends Analysis Report by Service (Primary Care, Urgent Care, Preventive Care, Mobile Clinical Testing, Chronic care Management) and Segment Forecasts, 2022-2030” report has been added to ResearchAndMarkets.com’s offering. The U.S. house calls market size is expected to reach USD 831.2 million by 2030 expanding at a … [Read more…]

Research Antibodies and Reagents Global Market Research Report 2022 Featuring Major Players – Abcam, Merck, Cell Signaling Technology, GE Healthcare, Thermo Fisher Scientific – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Research Antibodies and Reagents Global Market Report 2022: By Technology, By Application, By End-User” report has been added to ResearchAndMarkets.com’s offering. Research Antibodies and Reagents Global Market Report 2022 provides the strategists, marketers and senior management with the critical information they need to assess the global research antibodies and reagents market. This report … [Read more…]

Fujirebio Acquires ADx Neurosciences and Confirms Its Intentions to Bring Better and Earlier Neurodegenerative Disease Diagnostic Solutions to the Global Diagnostics Industry

GENT, Belgium & TOKYO–(BUSINESS WIRE)–H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and ADx NeuroSciences NV today announced the acquisition of ADx NeuroSciences by Fujirebio for 40 million euros. Pending the satisfaction of customary closing conditions, the deal is expected to close in July 2022. ADx NeuroSciences becomes a wholly owned subsidiary … [Read more…]

Twenty per cent of Canadians experienced increased workplace conflict or aggression

LifeWorks Mental Health Index™ finds 34 per cent of Canadians indicate their workplace does not provide training, coaching or support to deal with conflict or aggression TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health Index™ that showed the 20 per cent of Canadians that have … [Read more…]

Gold Standard Diagnostics, a Eurofins Technologies Company, Announces a PCR Assay for the Detection of the Monkeypox and Orthopox Virus

LUXEMBOURG–(BUSINESS WIRE)–Gold Standard Diagnostics Europe continues its response to the threat of emerging infectious diseases by developing a new multiplex Real-time PCR assay for the detection of the monkeypox virus and its differentiation from other orthopox viruses. The monkeypox virus has raised significant concerns given its recent spread, with more than 2500 confirmed cases in … [Read more…]

Innate Pharma to Participate in Upcoming Investor Conference

MARSEILLE, France–(BUSINESS WIRE)–Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced that its investor relation team will participate in the following upcoming investor conference: Conference Portzamparc – Evenement Corporate Access, Paris (in-person event) Event Date: June 30, 2022 About Innate Pharma: Innate Pharma S.A. is a global, clinical-stage … [Read more…]